» Articles » PMID: 37046804

Lipid Metabolic Reprogramming in Embryonal Neoplasms with MYCN Amplification

Overview
Journal Cancers (Basel)
Publisher MDPI
Specialty Oncology
Date 2023 Apr 13
PMID 37046804
Authors
Affiliations
Soon will be listed here.
Abstract

Tumor cells reprogram their metabolism, including glucose, glutamine, nucleotide, lipid, and amino acids to meet their enhanced energy demands, redox balance, and requirement of biosynthetic substrates for uncontrolled cell proliferation. Altered lipid metabolism in cancer provides lipids for rapid membrane biogenesis, generates the energy required for unrestricted cell proliferation, and some of the lipids act as signaling pathway mediators. In this review, we focus on the role of lipid metabolism in embryonal neoplasms with MYCN dysregulation. We specifically review lipid metabolic reactions in neuroblastoma, retinoblastoma, medulloblastoma, Wilms tumor, and rhabdomyosarcoma and the possibility of targeting lipid metabolism. Additionally, the regulation of lipid metabolism by the MYCN oncogene is discussed.

Citing Articles

Molecular pathway of anticancer effect of next-generation HSP90 inhibitors XL-888 and Debio0932 in neuroblastoma cell line.

Kaplan O, Tosun N Med Oncol. 2024; 41(8):194.

PMID: 38958814 PMC: 11222184. DOI: 10.1007/s12032-024-02428-z.


Evolving Diagnostic and Treatment Strategies for Pediatric CNS Tumors: The Impact of Lipid Metabolism.

Fernandez-Garcia P, Malet-Engra G, Torres M, Hanson D, Rossello C, Roman R Biomedicines. 2023; 11(5).

PMID: 37239036 PMC: 10216525. DOI: 10.3390/biomedicines11051365.

References
1.
Tomek K, Wagner R, Varga F, Singer C, Karlic H, Grunt T . Blockade of fatty acid synthase induces ubiquitination and degradation of phosphoinositide-3-kinase signaling proteins in ovarian cancer. Mol Cancer Res. 2011; 9(12):1767-79. DOI: 10.1158/1541-7786.MCR-10-0467. View

2.
Williams R, Al-Saadi R, Natrajan R, Mackay A, Chagtai T, Little S . Molecular profiling reveals frequent gain of MYCN and anaplasia-specific loss of 4q and 14q in Wilms tumor. Genes Chromosomes Cancer. 2011; 50(12):982-95. DOI: 10.1002/gcc.20907. View

3.
Tirinato L, Liberale C, Di Franco S, Candeloro P, Benfante A, La Rocca R . Lipid droplets: a new player in colorectal cancer stem cells unveiled by spectroscopic imaging. Stem Cells. 2014; 33(1):35-44. PMC: 4311668. DOI: 10.1002/stem.1837. View

4.
Camarda R, Zhou A, Kohnz R, Balakrishnan S, Mahieu C, Anderton B . Inhibition of fatty acid oxidation as a therapy for MYC-overexpressing triple-negative breast cancer. Nat Med. 2016; 22(4):427-32. PMC: 4892846. DOI: 10.1038/nm.4055. View

5.
Pike L, Smift A, Croteau N, Ferrick D, Wu M . Inhibition of fatty acid oxidation by etomoxir impairs NADPH production and increases reactive oxygen species resulting in ATP depletion and cell death in human glioblastoma cells. Biochim Biophys Acta. 2011; 1807(6):726-34. DOI: 10.1016/j.bbabio.2010.10.022. View